Bio Middle East

Description

BIO Middle East 2026 is the Middle East’s premier biotechnology and life sciences conference and exhibition, taking place 11–13 May 2026 at the Riyadh Exhibition & Convention Center (Malham) in Saudi Arabia. It serves as a strategic platform for global and regional stakeholders—including biopharma leaders, investors, researchers, regulators and government policymakers—to connect, exchange insights and advance innovation across the full biotech value chain. The event features high‑level keynotes, expert panel sessions and deep dives into topics such as cell and gene therapies, next‑generation vaccines, biomanufacturing and cutting‑edge therapeutic development. With a focused agenda that balances scientific insight with commercial opportunity, BIO Middle East aims to accelerate collaboration and growth in the rapidly expanding Middle East and Africa biotech market.
In addition to its conference programme, BIO Middle East offers structured networking and business matchmaking through the PartneringONE® platform, enabling curated one‑to‑one meetings that help establish investment, licensing and strategic partnerships. The event also includes innovation pitch stages where startups and SMEs can present breakthrough technologies to investors and industry leaders, as well as side events designed to foster informal connections and community building. Co‑located with the CPHI Middle East pharmaceutical exhibition, the conference brings together thousands of visitors, hundreds of exhibitors and global decision‑makers under one roof to shape the future of biotechnology in the region and beyond.